<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04517734</url>
  </required_header>
  <id_info>
    <org_study_id>0911001050</org_study_id>
    <nct_id>NCT04517734</nct_id>
  </id_info>
  <brief_title>Erythroferrone and Its Impact on Maternal and Neonatal Iron Homeostasis</brief_title>
  <official_title>Erythroferrone and Its Impact on Maternal and Neonatal Iron Homeostasis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cornell University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cornell University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Erythroferrone (ERFE) is a recently identified iron-regulatory hormone that couples iron&#xD;
      homeostasis to erythropoiesis but at this time there are no human data on this hormone in&#xD;
      pregnant women and their neonates. The investigators hypothesize that ERFE is a sensitive&#xD;
      biomarker of iron deficiency and anemia in pregnancy and neonates, and that it mediates the&#xD;
      feedback mechanism to correct iron deficiency and anemia. To address this research gap, the&#xD;
      investigators will measure ERFE in maternal serum, umbilical cord serum and placental tissue&#xD;
      using an existing biospecimen archive.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2006</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Maternal Erythroferrone During Pregnancy</measure>
    <time_frame>Measures will be obtained from maternal blood collected throughout the 40 weeks of pregnancy</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Maternal Erythroferrone at Delivery</measure>
    <time_frame>Measures will be obtained from maternal blood collected at delivery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Neonatal Erythroferrone at Birth</measure>
    <time_frame>Measures will be obtained from umbilical cord blood collected at delivery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Placental Erythroferrone mRNA and Ferroportin protein Expression</measure>
    <time_frame>Measures will be obtained from placental samples collected at delivery</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">338</enrollment>
  <condition>Pregnancy Anemia</condition>
  <condition>Newborn; Anemia</condition>
  <arm_group>
    <arm_group_label>Pregnant Adolescents</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Pregnant Women Carrying Multiple Fetuses</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      During pregnancy 15 mL maternal blood sample collected. At delivery 15 mL maternal blood&#xD;
      sample, 20 mL umbilical cord blood sample and the placenta are collected.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women carrying multiple fetuses (twins, triplets and quadruplets) or pregnant&#xD;
        adolescents carrying a single fetus&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy pregnant volunteers&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Hemoglobinopathies&#xD;
&#xD;
          -  Pre-existing diabetes&#xD;
&#xD;
          -  Malabsorption diseases&#xD;
&#xD;
          -  Pregnancy induced hypertension&#xD;
&#xD;
          -  Elevated diastolic blood pressure (&gt;110)&#xD;
&#xD;
          -  Previous treatment for lead exposure or elevated childhood lead concentrations.&#xD;
&#xD;
          -  Preexisting medical conditions known to impact iron homeostasis&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>11 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kimberly O'Brien, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cornell University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elizabeta Nemeth, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rochester Adolescent Maternity Program</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Strong Memorial Hospital</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14620</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 11, 2020</study_first_submitted>
  <study_first_submitted_qc>August 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 18, 2020</study_first_posted>
  <last_update_submitted>August 17, 2020</last_update_submitted>
  <last_update_submitted_qc>August 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cornell University</investigator_affiliation>
    <investigator_full_name>Kimberly O'Brien</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

